멜라토닌 관련 불면증

References

1. [1] Richard I Shader. J Clin Psychopharmacol. Question: Is it safe for people with cancer and other serious conditions to combine cannabidiol with melatonin when neither has … doi:10.1097/JCP.0000000000002024 PubMed
2. [2] Rayan Kteish et al.. Pediatr Rev. 2026. Pediatric Insomnia. doi:10.1542/pir.2024-006687 PubMed
3. [3] Yi Shu et al.. Phytomedicine. 2026. Compound Chaijin Jieyu Fang alleviates insomnia complicated with depression by reshaping actinobacteria to inhibit neuronal apoptosis. doi:10.1016/j.phymed.2025.157632 PubMed
4. [4] Xiaoyan Liu et al.. Eur J Pharm Biopharm. 2026. A bedside-savior for insomnia and anxiety disorders: melatonin/buspirone hydrochloride compound oral fast-dissolving film. doi:10.1016/j.ejpb.2025.114930 PubMed
5. [5] Ai Terui et al.. PCN Rep. 2026. Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children with autism spectrum disorder. doi:10.1002/pcn5.70294 PubMed
6. [6] Alessandro Colitta et al.. J Pineal Res. 2026. Navigating Melatonin Safety: Fact, Fiction, and Confounders. doi:10.1111/jpi.70129 PubMed
7. [7] Laura Palagini et al.. Sleep Med. 2025. Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus … doi:10.1016/j.sleep.2025.01.033 PubMed
8. [8] Melatonin Task Force et al.. Sleep Med. 2025. Melatonin use in typically developing (TD) children: International Pediatric Sleep Association (IPSA) Expert Consensus Recommendations for Healthcare Providers. doi:10.1016/j.sleep.2025.02.002 PubMed
9. [9] Roberto León-Barriera et al.. Cleve Clin J Med. 2025. Insomnia in older adults: A review of treatment options. doi:10.3949/ccjm.92a.24073 PubMed
10. [10] Claudia R C Moreno. Handb Clin Neurol. 2025. Shift work sleep disorder. doi:10.1016/B978-0-323-90918-1.00015-0 PubMed
11. [11] Matthew W Kaufman et al.. Am J Lifestyle Med. 2025. Nutritional Supplements for Healthy Aging: A Critical Analysis Review. doi:10.1177/15598276241244725 PubMed
12. [12] Adriana Salame et al.. Sleep Med. 2025. Over-the-counter products for insomnia in adults: A scoping review of randomised controlled trials. doi:10.1016/j.sleep.2025.02.027 PubMed
13. [13] Aleksandar Videnovic et al.. Handb Clin Neurol. 2025. Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment. doi:10.1016/B978-0-323-90918-1.00006-X PubMed
14. [14] Jolijn Boer et al.. J Clin Sleep Med. 2025. Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany. doi:10.5664/jcsm.11334 PubMed
15. [15] Wedad S Sarawi. Mol Neurobiol. 2025. Neurochemical Insights into the Role of Tryptophan Metabolites and Kynurenine Pathway in Insomnia and its Psychological and Neurological Comorbidities. doi:10.1007/s12035-025-05210-y PubMed
16. [16] Zirong Li et al.. Neurosci Lett. 2025. Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS + SD rats leading to … doi:10.1016/j.neulet.2024.138091 PubMed
17. [17] Kacper Żełabowski et al.. Molecules. 2025. The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs. doi:10.3390/molecules30183814 PubMed
18. [18] Mohammad Amrollahi-Sharifabadi et al.. Chem Biol Interact. 2025. Melatonin's paradox: From therapeutic benefits to toxicity warnings. doi:10.1016/j.cbi.2025.111556 PubMed
19. [19] Brandon Luu et al.. Front Psychiatry. 2025. ADHD as a circadian rhythm disorder: evidence and implications for chronotherapy. doi:10.3389/fpsyt.2025.1697900 PubMed
20. [20] Shobha George et al.. CNS Spectr. 2025. Melatonin dose and timing: Do we have it right? doi:10.1017/S109285292510062X PubMed
21. [21] Naoise C Synnott et al.. PLoS One. 2025. Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial. doi:10.1371/journal.pone.0332366 PubMed
22. [22] Hannah Scott et al.. J Pineal Res. 2025. Circadian Rhythm Timing and Associations With Sleep Symptoms in People With Insomnia. doi:10.1111/jpi.70069 PubMed
23. [23] Keith A Barnes. JAAPA. 2025. Delayed sleep-wake phase disorder. doi:10.1097/01.JAA.0000000000000096 PubMed
24. [24] Tatiana Palotta Minari et al.. Sleep Breath. 2025. Unraveling the connection between the Mediterranean diet and sleep health: from biological mechanisms to clinical implications. doi:10.1007/s11325-025-03546-2 PubMed
25. [25] Savithiri Ratnapalan et al.. Paediatr Child Health. 2025. Therapeutic Dilemma: Melatonin or not? doi:10.1093/pch/pxae083 PubMed
26. [26] Yongcheng Jiang et al.. Front Biosci (Landmark Ed). 2025. Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA. doi:10.31083/FBL39587 PubMed
27. [27] Bohong Zheng et al.. Pharmaceuticals (Basel). 2025. Unraveling Cannabidiol's Bidirectional Regulation of Melatonin Pharmacokinetics via PEPT1/CYP1A2: Mechanistic Insights and Quantitative Projections. doi:10.3390/ph19010080 PubMed
28. [28] Baojun Guo et al.. Neurochem Res. 2025. Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin Signaling Activation. doi:10.1007/s11064-025-04556-y PubMed
29. [29] Michael Gbadegesin et al.. Niger J Physiol Sci. 2025. D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats. doi:10.54548/njps.v39i1.7 PubMed
30. [30] Rosa M Ortega et al.. Nutr Hosp. 2025. [Nutrition in improving sleep quality and fighting insomnia]. doi:10.20960/nh.06090 PubMed
31. [31] Muhammad Zia Ul Haq et al.. Cochrane Database Syst Rev. 2025. Melatonin for blood pressure control in adults. doi:10.1002/14651858.CD016159 PubMed
32. [32] Rebecca L Kelley et al.. Hum Reprod. 2025. A prospective randomized controlled trial of antioxidants in human IVF and embryo culture media. doi:10.1093/humrep/deaf183 PubMed
33. [33] Min Jia et al.. Sleep Med Rev. 2025. Melatonin: beyond circadian regulation - exploring its diverse physiological roles and therapeutic potential. doi:10.1016/j.smrv.2025.102123 PubMed
34. [34] Christophe Langelet et al.. Biol Aujourdhui. 2025. [Sleep and neurodevelopment: a timely subject]. doi:10.1051/jbio/2025006 PubMed
35. [35] Stefano Comai et al.. J Pineal Res. 2024. Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views. doi:10.1111/jpi.13011 PubMed
36. [36] Francy Cruz-Sanabria et al.. J Pineal Res. 2024. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response … doi:10.1111/jpi.12985 PubMed
37. [37] Suresh Kotagal et al.. Sleep Med. 2024. Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric … doi:10.1016/j.sleep.2024.04.008 PubMed
38. [38] Ji Won Yeom et al.. Psychiatry Investig. 2024. Herbal and Natural Supplements for Improving Sleep: A Literature Review. doi:10.30773/pi.2024.0121 PubMed
39. [39] Harshith Chandra Shekhar et al.. Adv Ther. 2024. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical … doi:10.1007/s12325-023-02708-6 PubMed
40. [40] Eva Rames Nissen et al.. JNCI Cancer Spectr. 2024. Interventions for insomnia in cancer patients and survivors-a comprehensive systematic review and meta-analysis. doi:10.1093/jncics/pkae041 PubMed
41. [41] Laura Palagini et al.. J Neurol. 2024. Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group. doi:10.1007/s00415-023-12112-3 PubMed
42. [42] Oliviero Bruni et al.. Eur J Pediatr. 2024. European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children. doi:10.1007/s00431-024-05556-w PubMed
43. [43] Kazim Sahin et al.. Antioxidants (Basel). 2024. Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model. doi:10.3390/antiox13060657 PubMed
44. [44] Muhammad Saeed et al.. Poult Sci. 2024. Molecular strategies to enhance the keratinase gene expression and its potential implications in poultry feed industry. doi:10.1016/j.psj.2024.103606 PubMed
45. [45] Tian-Ji Xia et al.. J Ethnopharmacol. 2024. Shen Yuan extract exerts a hypnotic effect via the tryptophan/5-hydroxytryptamine/melatonin pathway in mice. doi:10.1016/j.jep.2024.117992 PubMed
46. [46] Haiqin Ren et al.. J Ethnopharmacol. 2024. The therapeutic potential of Ziziphi Spinosae Semen and Polygalae Radix in insomnia management: Insights from gut microbiota and serum metabolomics … doi:10.1016/j.jep.2024.118255 PubMed
47. [47] Bhavya Narala et al.. Curr Opin Pediatr. 2024. Delayed sleep wake phase disorder in adolescents: an updated review. doi:10.1097/MOP.0000000000001322 PubMed
48. [48] Kyle P Johnson et al.. Psychiatr Clin North Am. 2024. Autism Spectrum Disorder and Sleep. doi:10.1016/j.psc.2023.06.013 PubMed
49. [49] Marcela de Paiva Foletto-Felipe et al.. Plant Physiol Biochem. 2024. Inhibition of sulfur assimilation by S-benzyl-L-cysteine: Impacts on growth, photosynthesis, and leaf proteome of maize plants. doi:10.1016/j.plaphy.2024.109173 PubMed
50. [50] Sidra Khalid et al.. Front Endocrinol (Lausanne). 2024. Effects of magnesium and potassium supplementation on insomnia and sleep hormones in patients with diabetes mellitus. doi:10.3389/fendo.2024.1370733 PubMed
51. [51] Oliviero Bruni et al.. Sleep Med. 2024. Insomnia in children affected by autism spectrum disorder: The role of melatonin in treatment. doi:10.1016/j.sleep.2024.05.046 PubMed
52. [52] Cristian Falup-Pecurariu et al.. Expert Opin Pharmacother. 2024. Pharmacological and non-pharmacological management of sleep disturbances in Parkinson's disease: if when and how. doi:10.1080/14656566.2024.2422004 PubMed
53. [53] Christine Anh Burke et al.. Neurourol Urodyn. 2024. Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review. doi:10.1002/nau.25443 PubMed
54. [54] Judith Owens et al.. Sleep Med. 2024. Melatonin use in infants and toddlers. doi:10.1016/j.sleep.2024.06.008 PubMed
55. [55] Hsin-Chieh Kung et al.. Int J Mol Sci. 2024. Biosynthetic Pathways of Tryptophan Metabolites in Saccharomyces cerevisiae Strain: Insights and Implications. doi:10.3390/ijms25094747 PubMed
56. [56] Ruwani Mendis et al.. J Palliat Med. 2024. Temazepam or Melatonin Versus Placebo for the Treatment of Insomnia in Advanced Cancer: A Three-Arm, Double-Blind, Phase III, Multicenter, Randomized … doi:10.1089/jpm.2024.0151 PubMed
57. [57] Rachael Frost et al.. BMC Complement Med Ther. 2024. A scoping review of over-the-counter products for depression, anxiety and insomnia in older people. doi:10.1186/s12906-024-04585-0 PubMed
58. [58] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
59. [59] Anita Chabo et al.. Am J Lifestyle Med. 2024. Catching ZZZs: A Summary of the Most Common Herbal Medications Taken for Insomnia. doi:10.1177/15598276241232953 PubMed
60. [60] Antonio Del Casale et al.. Minerva Med. 2024. The use of prolonged-release melatonin in circadian medicine: a systematic review. doi:10.23736/S0026-4806.24.09303-0 PubMed
61. [61] Madhuri S Kurdi et al.. Indian J Palliat Care. 2024. Comparison Between Efficacy of Oral Melatonin and Oral L-theanine in Improving Sleep in Cancer Patients Suffering From Insomnia: A Randomised … doi:10.25259/IJPC_89_2023 PubMed
62. [62] Daniele Giuseppe Buccato et al.. Nutrients. 2024. Efficacy and Tolerability of a Food Supplement Based on Zea mays L., Gymnema sylvestre (Retz.) R.br.ex Sm, Zinc and Chromium … doi:10.3390/nu16152459 PubMed
63. [63] Sonia Gago et al.. Reprod Domest Anim. 2024. Impact of N-acetyl-L-cysteine on spindle morphology and reactive oxygen species in vitrified/warmed in vitro matured bovine oocytes. doi:10.1111/rda.14619 PubMed
64. [64] I V Zhdanova et al.. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. [Melatonin for the regulation of sleep and other biological rhythms]. doi:10.17116/jnevro20241240528 PubMed
65. [65] Marie-Françoise Vecchierini et al.. Rev Prat. 2024. [Pharmacotherapies for insomnia]. PubMed
66. [66] Andrea Herrera et al.. J Diet Suppl. 2024. Effects of the PREMEN-CALM® in the Management of the Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. doi:10.1080/19390211.2023.2301398 PubMed
67. [67] Dieter Riemann et al.. J Sleep Res. 2023. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. doi:10.1111/jsr.14035 PubMed
68. [68] Colin Tuft et al.. Clin Interv Aging. 2023. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. doi:10.2147/CIA.S361519 PubMed
69. [69] Karin Ried et al.. J Sleep Res. 2023. Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study. doi:10.1111/jsr.13793 PubMed
70. [70] Francy Cruz-Sanabria et al.. Curr Neuropharmacol. 2023. Melatonin as a Chronobiotic with Sleep-promoting Properties. doi:10.2174/1570159X20666220217152617 PubMed
71. [71] Mei Xiong et al.. Neuropediatrics. 2023. Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis. doi:10.1055/s-0043-1761437 PubMed
72. [72] Julia Maruani et al.. J Sleep Res. 2023. Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and … doi:10.1111/jsr.13939 PubMed
73. [73] Tian-Ji Xia et al.. Front Pharmacol. 2023. Melatonin-related dysfunction in chronic restraint stress triggers sleep disorders in mice. doi:10.3389/fphar.2023.1210393 PubMed
74. [74] Johanna Ell et al.. J Sleep Res. 2023. Complementary and alternative treatments for insomnia disorder: a systematic umbrella review. doi:10.1111/jsr.13979 PubMed
75. [75] Ao Huang et al.. J Acupunct Meridian Stud. 2023. Ziwuliuzhu Acupuncture Modulates Clock mRNA, Bmal1 mRNA and Melatonin in Insomnia Rats. doi:10.51507/j.jams.2023.16.3.109 PubMed
76. [76] Nedjma Labani et al.. Pharmaceutics. 2023. Pistacia vera Extract Potentiates the Effect of Melatonin on Human Melatonin MT1 and MT2 Receptors with Functional Selectivity. doi:10.3390/pharmaceutics15071845 PubMed
77. [77] Alessandra Giordano et al.. J Clin Neurophysiol. 2023. Objective Diagnosis of Circadian Rhythm Disorders. doi:10.1097/WNP.0000000000000951 PubMed
78. [78] Alexandra Wu. Sleep Biol Rhythms. 2023. Updates and confounding factors in delayed sleep-wake phase disorder. doi:10.1007/s41105-023-00454-4 PubMed
79. [79] Swapna N Deshpande et al.. Child Adolesc Psychiatr Clin N Am. 2023. Complementary and Integrative Approaches to Sleep Disorders in Children. doi:10.1016/j.chc.2022.08.008 PubMed
80. [80] Nicole Pesantes et al.. Front Microbiol. 2023. Influence of mental health medication on microbiota in the elderly population in the Valencian region. doi:10.3389/fmicb.2023.1094071 PubMed
81. [81] Stephen C Bondy. Subcell Biochem. 2023. Melatonin and Aging. doi:10.1007/978-3-031-26576-1_13 PubMed
82. [82] Mrinalini Ravikumar et al.. Curr Drug Saf. 2023. The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease. doi:10.2174/1574886317666220517125644 PubMed
83. [83] Birgitta Dresp-Langley et al.. Int J Environ Res Public Health. 2022. Digital Addiction and Sleep. doi:10.3390/ijerph19116910 PubMed
84. [84] J J Poza et al.. Neurologia (Engl Ed). 2022. Melatonin in sleep disorders. doi:10.1016/j.nrl.2018.08.002 PubMed
85. [85] Saptadip Samanta. Arch Physiol Biochem. 2022. Physiological and pharmacological perspectives of melatonin. doi:10.1080/13813455.2020.1770799 PubMed
86. [86] Kyungseon Choi et al.. Sleep Med Rev. 2022. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. doi:10.1016/j.smrv.2022.101692 PubMed
87. [87] J J Poza et al.. Neurologia (Engl Ed). 2022. Melatonin in sleep disorders. doi:10.1016/j.nrleng.2018.08.004 PubMed
88. [88] Shi-Yu Sun et al.. Curr Neuropharmacol. 2022. Treatment of Circadian Rhythm Sleep-Wake Disorders. doi:10.2174/1570159X19666210907122933 PubMed
89. [89] Tya Vine et al.. Braz J Psychiatry. 2022. Melatonin use during pregnancy and lactation: A scoping review of human studies. doi:10.1590/1516-4446-2021-2156 PubMed
90. [90] Bárbara Carriedo-Diez et al.. Int J Environ Res Public Health. 2022. The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review. doi:10.3390/ijerph191610199 PubMed
91. [91] Niall M McGowan et al.. CNS Drugs. 2022. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis. doi:10.1007/s40263-022-00911-7 PubMed
92. [92] C M Schröder et al.. Encephale. 2022. [Therapeutic approaches for sleep and rhythms disorders in children with ASD]. doi:10.1016/j.encep.2021.08.005 PubMed
93. [93] Nava Zisapel. Expert Rev Clin Pharmacol. 2022. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with … doi:10.1080/17512433.2022.2053520 PubMed
94. [94] Arpita Shah et al.. Metab Syndr Relat Disord. 2022. Is Shift Work Sleep Disorder a Risk Factor for Metabolic Syndrome and Its Components? A Systematic Review of Cross-Sectional Studies. doi:10.1089/met.2021.0070 PubMed
95. [95] Cezary Chojnacki et al.. Int J Mol Sci. 2022. A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life … doi:10.3390/ijms232315314 PubMed
96. [96] D E Alcantara-Zapata et al.. Front Physiol. 2022. Women's mood at high altitude. sexual dimorphism in hypoxic stress modulation by the tryptophan-melatonin axis. doi:10.3389/fphys.2022.1099276 PubMed
97. [97] Hongda Liu et al.. Front Pharmacol. 2022. Evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia … doi:10.3389/fphar.2022.1009668 PubMed
98. [98] Abdolkarim Hosseini et al.. Fundam Clin Pharmacol. 2022. Melatonin as a complementary and prophylactic agent against COVID-19 in high-risk populations: A narrative review of recent findings from clinical … doi:10.1111/fcp.12805 PubMed
99. [99] Na Pan et al.. Sci Total Environ. 2022. Inhibitory effects of zinc chloride (ZnCl2), n-acetyl-L-cysteine (NAC), and calcium/calmodulin dependent protein kinase II inhibitor (KN93) on Cd2+-induced abnormal cell … doi:10.1016/j.scitotenv.2022.155208 PubMed
100. [100] G Palmieri et al.. Clin Ter. 2022. Insomnia treatment: a new multitasking natural compound based on melatonin and cannabis extracts. doi:10.7417/CT.2022.2399 PubMed
101. [101] Deemah Alateeq et al.. Saudi Pharm J. 2022. The use of dietary supplements for mental health among the Saudi population: A cross-sectional survey. doi:10.1016/j.jsps.2022.03.017 PubMed
102. [102] Punita Peketi et al.. J Am Med Dir Assoc. 2022. Melatonin Prescribing in Assisted Living. doi:10.1016/j.jamda.2021.10.005 PubMed
103. [103] Qinggong Wang et al.. Nat Commun. 2022. Structural basis of the ligand binding and signaling mechanism of melatonin receptors. doi:10.1038/s41467-022-28111-3 PubMed
104. [104] Faris M Zuraikat et al.. Annu Rev Nutr. 2021. Sleep and Diet: Mounting Evidence of a Cyclical Relationship. doi:10.1146/annurev-nutr-120420-021719 PubMed
105. [105] Dewan Md Sumsuzzman et al.. Neurosci Biobehav Rev. 2021. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis … doi:10.1016/j.neubiorev.2021.04.034 PubMed
106. [106] Tyler A Steele et al.. Neurotherapeutics. 2021. Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease. doi:10.1007/s13311-021-01031-8 PubMed
107. [107] Pierre A Geoffroy et al.. Prog Neuropsychopharmacol Biol Psychiatry. 2021. Biological rhythms and chronotherapeutics in depression. doi:10.1016/j.pnpbp.2020.110158 PubMed
108. [108] Kyle P Johnson et al.. Child Adolesc Psychiatr Clin N Am. 2021. Autism Spectrum Disorder and Sleep. doi:10.1016/j.chc.2020.08.012 PubMed
109. [109] Landon Hester et al.. Chronobiol Int. 2021. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. doi:10.1080/07420528.2021.1930029 PubMed
110. [110] Carmen M Schroder et al.. Expert Opin Pharmacother. 2021. Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders. doi:10.1080/14656566.2021.1959549 PubMed
111. [111] Adrian L Lopresti et al.. Sleep Med. 2021. An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults … doi:10.1016/j.sleep.2021.08.001 PubMed
112. [112] Azar Jafari-Koulaee et al.. Sleep Med. 2021. The effect of melatonin on sleep quality and insomnia in patients with cancer: a systematic review study. doi:10.1016/j.sleep.2021.03.040 PubMed
113. [113] Xiao-Qiu Wang et al.. Zhongguo Zhen Jiu. 2021. [Effect of electroacupuncture on serum melatonin and dopamine in aged insomnia]. doi:10.13703/j.0255-2930.20200404-k0001 PubMed
114. [114] Ruhi Ali et al.. Comb Chem High Throughput Screen. 2021. Nutraceuticals for Sleep Disorders. doi:10.2174/1386207324666210121111446 PubMed
115. [115] Ana Paula Rosinski Bueno et al.. Arq Neuropsiquiatr. 2021. Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review. doi:10.1590/0004-282X-ANP-2020-0379 PubMed
116. [116] Sandrah-Ann M Almond et al.. Sr Care Pharm. 2021. A Systematic Review of the Efficacy and Safety of Over-the-Counter Medications Used in Older People for the Treatment of Primary … doi:10.4140/TCP.n.2021.83 PubMed
117. [117] Paolo Curatolo et al.. Nutrients. 2021. Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders. doi:10.3390/nu13051631 PubMed
118. [118] Ovidio Hernando-Requejo et al.. Nutr Hosp. 2021. [Nutrition impact on insomnia treatment]. doi:10.20960/nh.03359 PubMed
119. [119] Alberto Herrero Babiloni et al.. J Neural Transm (Vienna). 2020. Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship. doi:10.1007/s00702-019-02067-z PubMed
120. [120] P Proserpio et al.. Climacteric. 2020. Insomnia and menopause: a narrative review on mechanisms and treatments. doi:10.1080/13697137.2020.1799973 PubMed
121. [121] José Rafael P Zuzuárregui et al.. Neurotherapeutics. 2020. Sleep Issues in Parkinson's Disease and Their Management. doi:10.1007/s13311-020-00938-y PubMed
122. [122] Sha Wei et al.. Sleep Med. 2020. Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials. doi:10.1016/j.sleep.2019.02.017 PubMed
123. [123] Tian Ling Low et al.. J Psychiatr Res. 2020. The efficacy of melatonin and melatonin agonists in insomnia - An umbrella review. doi:10.1016/j.jpsychires.2019.10.022 PubMed
124. [124] Huajun Xu et al.. Sleep Med. 2020. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. doi:10.1016/j.sleep.2020.10.018 PubMed
125. [125] Judith Sys et al.. Eur J Clin Pharmacol. 2020. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review. doi:10.1007/s00228-019-02812-z PubMed
126. [126] Luigi Ferini-Strambi et al.. Curr Treat Options Neurol. 2020. Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease. doi:10.1007/s11940-020-0612-z PubMed
127. [127] Sylvie Dujardin et al.. Sleep Med Clin. 2020. Prescription Drugs Used in Insomnia. doi:10.1016/j.jsmc.2020.02.002 PubMed
128. [128] Jintana Sangsopha et al.. J Food Sci Technol. 2020. Dietary sources of melatonin and benefits from production of high melatonin pasteurized milk. doi:10.1007/s13197-020-04236-5 PubMed
129. [129] Armando L Morera-Fumero et al.. Drug Alcohol Depend. 2020. Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review. doi:10.1016/j.drugalcdep.2020.107994 PubMed
130. [130] Fengqi Yang et al.. Foods. 2020. Effect of L-cysteine, Boswellia serrata, and Whey Protein on the Antioxidant and Physicochemical Properties of Pork Patties. doi:10.3390/foods9080993 PubMed
131. [131] Gwang-Ho Kim et al.. Food Sci Nutr. 2020. Sleep-inducing effect of Passiflora incarnata L. extract by single and repeated oral administration in rodent animals. doi:10.1002/fsn3.1341 PubMed
132. [132] Lucia Pucciarini et al.. J Pharm Biomed Anal. 2020. Optimized one-pot derivatization and enantioseparation of cysteine: Application to the study of a dietary supplement. doi:10.1016/j.jpba.2019.113066 PubMed
133. [133] Terumi Ayuse et al.. Medicine (Baltimore). 2020. Study on the preventive effect of ramelteon on the onset of sleep disorder after general anesthesia in patients with autism … doi:10.1097/MD.0000000000022826 PubMed
134. [134] Ping Mi et al.. Chemosphere. 2020. Melatonin attenuates 17β-trenbolone induced insomnia-like phenotype and movement deficiency in zebrafish. doi:10.1016/j.chemosphere.2020.126762 PubMed
135. [135] . Med Lett Drugs Ther. 2020. Melatonin for insomnia in children. PubMed
136. [136] Benjamin Stauch et al.. Nature. 2019. Structural basis of ligand recognition at the human MT1 melatonin receptor. doi:10.1038/s41586-019-1141-3 PubMed
137. [137] Tian Li et al.. J Pineal Res. 2019. Melatonin: Another avenue for treating osteoporosis? doi:10.1111/jpi.12548 PubMed
138. [138] Susanna Esposito et al.. J Transl Med. 2019. Pediatric sleep disturbances and treatment with melatonin. doi:10.1186/s12967-019-1835-1 PubMed
139. [139] Jade M Murray et al.. Sleep Med. 2019. Sleep regularity is associated with sleep-wake and circadian timing, and mediates daytime function in Delayed Sleep-Wake Phase Disorder. doi:10.1016/j.sleep.2019.03.009 PubMed
140. [140] Oliviero Bruni et al.. Expert Opin Pharmacother. 2019. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. doi:10.1080/14656566.2019.1674283 PubMed
141. [141] R Velasco-Rodríguez et al.. Complement Ther Med. 2019. The effect of aromatherapy with lavender (Lavandula angustifolia) on serum melatonin levels. doi:10.1016/j.ctim.2019.102208 PubMed
142. [142] Patrick Lemoine et al.. Complement Ther Med. 2019. A combination of melatonin, vitamin B6 and medicinal plants in the treatment of mild-to-moderate insomnia: A prospective pilot study. doi:10.1016/j.ctim.2019.05.024 PubMed
143. [143] Aleksi J Hendricks et al.. Dermatitis. 2019. Clinical Pearls on Sleep Management in Atopic Dermatitis. doi:10.1097/DER.0000000000000523 PubMed
144. [144] Gwang-Ho Kim et al.. Lab Anim Res. 2019. Chronic oral administration of Passiflora incarnata extract has no abnormal effects on metabolic and behavioral parameters in mice, except to … doi:10.1186/s42826-019-0034-9 PubMed
145. [145] Argelinda Baroni. J Am Acad Child Adolesc Psychiatry. 2019. Teens Who Can't Sleep: Insomnia or Circadian Rhythm Disorder? doi:10.1016/j.jaac.2018.11.010 PubMed
146. [146] S Huysmans et al.. Tijdschr Psychiatr. 2019. [Melatonin and sleep disorders: Overview of literature and testing in psychiatric practice]. PubMed
147. [147] . Med Lett Drugs Ther. 2019. Advice for travelers. PubMed
148. [148] Nava Zisapel. Br J Pharmacol. 2018. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. doi:10.1111/bph.14116 PubMed
149. [149] Athanasios Maras et al.. J Child Adolesc Psychopharmacol. 2018. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. doi:10.1089/cap.2018.0020 PubMed
150. [150] Vivien C Abad et al.. Drugs Aging. 2018. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. doi:10.1007/s40266-018-0569-8 PubMed
151. [151] Nanfu Deng et al.. Sex Med Rev. 2018. The Relationship Between Shift Work and Men's Health. doi:10.1016/j.sxmr.2017.11.009 PubMed
152. [152] Renata L Riha. Curr Opin Pulm Med. 2018. The use and misuse of exogenous melatonin in the treatment of sleep disorders. doi:10.1097/MCP.0000000000000522 PubMed
153. [153] Cemal Cingi et al.. Travel Med Infect Dis. 2018. Jetlag related sleep problems and their management: A review. doi:10.1016/j.tmaid.2018.05.008 PubMed
154. [154] M-A Quera-Salva et al.. Encephale. 2018. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia]. doi:10.1016/j.encep.2018.06.005 PubMed
155. [155] Bhavesh Trikamji et al.. Cureus. 2018. Recurrent Chemical Meningitis Due to Parasellar Epidermoid Cyst. doi:10.7759/cureus.3496 PubMed
156. [156] Amalie Berring-Uldum et al.. Ugeskr Laeger. 2018. [Melatonin for children with insomnia]. PubMed
157. [157] Jean Dumur et al.. Rev Med Suisse. 2018. [Which alternative to benzodiazepines, Z-pills and other hypnotics for aged people ? Melatonin, valerian, or clomethiazole]. PubMed
158. [158] Kai-Ming Duan et al.. Metab Brain Dis. 2018. The role of tryptophan metabolism in postpartum depression. doi:10.1007/s11011-017-0178-y PubMed
159. [159] J M J Stoffels et al.. Ned Tijdschr Geneeskd. 2018. [Insomnia in hospital]. PubMed
160. [160] Dieter Riemann et al.. J Sleep Res. 2017. European guideline for the diagnosis and treatment of insomnia. doi:10.1111/jsr.12594 PubMed
161. [161] Michael J Sateia et al.. J Clin Sleep Med. 2017. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice … doi:10.5664/jcsm.6470 PubMed
162. [162] Zizhen Xie et al.. Neurol Res. 2017. A review of sleep disorders and melatonin. doi:10.1080/01616412.2017.1315864 PubMed
163. [163] Xiao Meng et al.. Nutrients. 2017. Dietary Sources and Bioactivities of Melatonin. doi:10.3390/nu9040367 PubMed
164. [164] Paul Gringras et al.. J Am Acad Child Adolesc Psychiatry. 2017. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. doi:10.1016/j.jaac.2017.09.414 PubMed
165. [165] Lauren A E Erland et al.. J Clin Sleep Med. 2017. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. doi:10.5664/jcsm.6462 PubMed
166. [166] Milena Pavlova. Continuum (Minneap Minn). 2017. Circadian Rhythm Sleep-Wake Disorders. doi:10.1212/CON.0000000000000499 PubMed
167. [167] Eric Matheson et al.. Am Fam Physician. 2017. Insomnia: Pharmacologic Therapy. PubMed
168. [168] Amy W Amara et al.. Curr Treat Options Neurol. 2017. Treatment of Sleep Dysfunction in Parkinson's Disease. doi:10.1007/s11940-017-0461-6 PubMed
169. [169] Jonathan S Emens et al.. Drugs. 2017. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. doi:10.1007/s40265-017-0707-3 PubMed
170. [170] Shweta Anand et al.. Paediatr Drugs. 2017. Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological … doi:10.1007/s40272-017-0224-6 PubMed
171. [171] Deepa Burman. FP Essent. 2017. Sleep Disorders: Circadian Rhythm Sleep-Wake Disorders. PubMed
172. [172] G Almoznino et al.. Oral Dis. 2017. An update of management of insomnia in patients with chronic orofacial pain. doi:10.1111/odi.12637 PubMed
173. [173] Marketa Marvanova et al.. Pharmacy (Basel). 2017. Community Pharmacists' Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD. doi:10.3390/pharmacy5030042 PubMed
174. [174] Jiabei Liu et al.. Annu Rev Pharmacol Toxicol. 2016. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. doi:10.1146/annurev-pharmtox-010814-124742 PubMed
175. [175] Jennifer L Schroeck et al.. Clin Ther. 2016. Review of Safety and Efficacy of Sleep Medicines in Older Adults. doi:10.1016/j.clinthera.2016.09.010 PubMed
176. [176] Kelly M Brown et al.. Chest. 2016. Pediatric Insomnia. doi:10.1378/chest.15-0605 PubMed
177. [177] Lionel H Opie et al.. Eur Heart J Cardiovasc Pharmacother. 2016. Melatonin has multiorgan effects. doi:10.1093/ehjcvp/pvv037 PubMed
178. [178] Harris R Lieberman et al.. J Nutr. 2016. Tryptophan Intake in the US Adult Population Is Not Related to Liver or Kidney Function but Is Associated with Depression … doi:10.3945/jn.115.226969 PubMed
179. [179] Hiroshi Tsuneki et al.. Trends Endocrinol Metab. 2016. Sleep Control, GPCRs, and Glucose Metabolism. doi:10.1016/j.tem.2016.06.011 PubMed
180. [180] Thomas A Hogerheyde et al.. Stem Cells Int. 2016. Optimization of Corneal Epithelial Progenitor Cell Growth on Bombyx mori Silk Fibroin Membranes. doi:10.1155/2016/8310127 PubMed
181. [181] Zhe Qu et al.. Neuromolecular Med. 2016. Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration. doi:10.1007/s12017-016-8410-1 PubMed
182. [182] Juha Liira et al.. Sao Paulo Med J. 2015. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. doi:10.1590/1516-3180.20151331T1 PubMed
183. [183] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
184. [184] Kathryn J Reid et al.. Sleep Med Clin. 2015. Jet Lag and Shift Work Disorder. doi:10.1016/j.jsmc.2015.08.006 PubMed
185. [185] Hrayr Attarian et al.. Menopause. 2015. Treatment of chronic insomnia disorder in menopause: evaluation of literature. doi:10.1097/GME.0000000000000348 PubMed
186. [186] Pierre Alexis Geoffroy et al.. Curr Pharm Des. 2015. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. doi:10.2174/1381612821666150619093448 PubMed
187. [187] Larry Culpepper et al.. Prim Care Companion CNS Disord. 2015. Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. doi:10.4088/PCC.15r01798 PubMed
188. [188] Diego A Golombek et al.. Eur J Pharmacol. 2015. Some implications of melatonin use in chronopharmacology of insomnia. doi:10.1016/j.ejphar.2015.05.032 PubMed
189. [189] Sabra M Abbott et al.. Sleep Med Clin. 2015. Irregular Sleep-Wake Rhythm Disorder. doi:10.1016/j.jsmc.2015.08.005 PubMed
190. [190] D N Neubauer. Drugs Today (Barc). 2015. Tasimelteon for the treatment of non-24-hour sleep-wake disorder. doi:10.1358/dot.2015.51.1.2258364 PubMed
191. [191] Francisco Tortorolo et al.. Medwave. 2015. Is melatonin useful for jet lag? doi:10.5867/medwave.2015.6343 PubMed
192. [192] Mahaveer Singh et al.. Drug Discov Today. 2014. Melatonin: functions and ligands. doi:10.1016/j.drudis.2014.04.014 PubMed
193. [193] Juha Liira et al.. Cochrane Database Syst Rev. 2014. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. doi:10.1002/14651858.CD009776.pub2 PubMed
194. [194] Michael H Bloch et al.. Child Adolesc Psychiatr Clin N Am. 2014. Nutritional supplements for the treatment of ADHD. doi:10.1016/j.chc.2014.05.002 PubMed
195. [195] Yawen Zeng et al.. Curr Signal Transduct Ther. 2014. Strategies of Functional Foods Promote Sleep in Human Being. doi:10.2174/1574362410666150205165504 PubMed
196. [196] G Pin Arboledas et al.. An Pediatr (Barc). 2014. [Consensus document on the clinical use of melatonin in children and adolescents with sleep-onset insomnia]. doi:10.1016/j.anpedi.2014.03.011 PubMed
197. [197] R Ugarte Libano. An Pediatr (Barc). 2014. [Insomnia, melatonin and prudence]. doi:10.1016/j.anpedi.2014.06.014 PubMed
198. [198] Eduardo Ferracioli-Oda et al.. PLoS One. 2013. Meta-analysis: melatonin for the treatment of primary sleep disorders. doi:10.1371/journal.pone.0063773 PubMed
199. [199] Samuele Cortese et al.. J Am Acad Child Adolesc Psychiatry. 2013. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. doi:10.1016/j.jaac.2013.06.001 PubMed
200. [200] Phyllis C Zee et al.. Continuum (Minneap Minn). 2013. Circadian rhythm abnormalities. doi:10.1212/01.CON.0000427209.21177.aa PubMed
201. [201] Delwyn J Bartlett et al.. Med J Aust. 2013. Circadian rhythm disorders among adolescents: assessment and treatment options. doi:10.5694/mja13.10912 PubMed
202. [202] Jessica R Barrett et al.. J Child Adolesc Psychopharmacol. 2013. To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and … doi:10.1089/cap.2013.0059 PubMed
203. [203] Jeremy A Weingarten et al.. Chest. 2013. Air travel: effects of sleep deprivation and jet lag. doi:10.1378/chest.12-2963 PubMed
204. [204] Shingo Kitamura et al.. Biol Psychiatry. 2013. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type. doi:10.1016/j.biopsych.2012.06.027 PubMed
205. [205] Fatmah A M Al-Omary. Profiles Drug Subst Excip Relat Methodol. 2013. Melatonin: comprehensive profile. doi:10.1016/B978-0-12-407691-4.00005-8 PubMed
206. [206] Daniel P Cardinali et al.. J Pineal Res. 2012. Melatonin and its analogs in insomnia and depression. doi:10.1111/j.1600-079X.2011.00962.x PubMed
207. [207] Octavian C Ioachimescu et al.. Expert Opin Pharmacother. 2012. Pharmacotherapy of insomnia. doi:10.1517/14656566.2012.683860 PubMed
208. [208] Alberto Dominguez-Rodriguez. Expert Opin Investig Drugs. 2012. Melatonin in cardiovascular disease. doi:10.1517/13543784.2012.716037 PubMed
209. [209] Makoto Bannai et al.. Front Neurol. 2012. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. doi:10.3389/fneur.2012.00061 PubMed
210. [210] Flavia Cortesi et al.. J Sleep Res. 2012. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized … doi:10.1111/j.1365-2869.2012.01021.x PubMed
211. [211] Andrew D Krystal et al.. J Clin Psychiatry. 2012. Shift work disorder case studies: applying management principles in clinical practice. doi:10.4088/JCP.11073br4 PubMed
212. [212] Klaus Seppi et al.. Mov Disord. 2011. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. doi:10.1002/mds.23884 PubMed
213. [213] Mariangela Rondanelli et al.. J Am Geriatr Soc. 2011. The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled … doi:10.1111/j.1532-5415.2010.03232.x PubMed
214. [214] Monika Banach et al.. Pharmacol Rep. 2011. Melatonin in experimental seizures and epilepsy. doi:10.1016/s1734-1140(11)70393-0 PubMed
215. [215] Gilberto Spadoni et al.. CNS Neurosci Ther. 2011. Melatonin receptor agonists: new options for insomnia and depression treatment. doi:10.1111/j.1755-5949.2010.00197.x PubMed
216. [216] Venkatramanujan Srinivasan et al.. Prog Neuropsychopharmacol Biol Psychiatry. 2011. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? doi:10.1016/j.pnpbp.2011.03.013 PubMed
217. [217] D Alan Lankford. Expert Opin Investig Drugs. 2011. Tasimelteon for insomnia. doi:10.1517/13543784.2011.583235 PubMed
218. [218] J Jarratt. Anaesth Intensive Care. 2011. Perioperative melatonin use. doi:10.1177/0310057X1103900205 PubMed
219. [219] Rachel E Fargason et al.. Psychopharmacol Bull. 2011. Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD). doi:10.64719/pb.4063 PubMed
220. [220] Eloisa Gitto et al.. J Pineal Res. 2011. Update on the use of melatonin in pediatrics. doi:10.1111/j.1600-079X.2010.00814.x PubMed
221. [221] Wilfred R Pigeon et al.. J Med Food. 2010. Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study. doi:10.1089/jmf.2009.0096 PubMed
222. [222] Venkatramanujam Srinivasan et al.. Adv Ther. 2010. Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. doi:10.1007/s12325-010-0065-y PubMed
223. [223] Sally A Ferguson et al.. Expert Rev Neurother. 2010. Melatonin agonists and insomnia. doi:10.1586/ern.10.1 PubMed
224. [224] A M Mazotto et al.. Lett Appl Microbiol. 2010. Keratinolytic activity of Bacillus subtilis AMR using human hair. doi:10.1111/j.1472-765X.2009.02760.x PubMed
225. [225] David E McCarty. Nat Sci Sleep. 2010. Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag. doi:10.2147/nss.s6680 PubMed
226. [226] Phyllis C Zee et al.. Curr Treat Options Neurol. 2010. Treatment of shift work disorder and jet lag. doi:10.1007/s11940-010-0090-9 PubMed
227. [227] Robert L Sack. Travel Med Infect Dis. 2009. The pathophysiology of jet lag. doi:10.1016/j.tmaid.2009.01.006 PubMed
228. [228] Kathryn J Reid et al.. Semin Neurol. 2009. Circadian rhythm disorders. doi:10.1055/s-0029-1237120 PubMed
229. [229] Dieter Riemann et al.. Nervenarzt. 2009. [Insomnias. II. Pharmacological and psychotherapeutic treatment options]. doi:10.1007/s00115-009-2746-9 PubMed
230. [230] Ståle Pallesen et al.. Tidsskr Nor Laegeforen. 2009. [Circadian rhythm sleep disorders]. doi:10.4045/tidsskr.08.0226 PubMed
231. [231] . Drug Ther Bull. 2009. Melatonin for primary insomnia? doi:10.1136/dtb.2009.06.0024 PubMed
232. [232] Feride Gökben Hizli et al.. Turk Psikiyatri Derg. 2009. [Delayed sleep phase type sleep disorder and chronotherapy]. PubMed
233. [233] Anne-Marie Chang et al.. J Biol Rhythms. 2009. Sleep timing and circadian phase in delayed sleep phase syndrome. doi:10.1177/0748730409339611 PubMed
234. [234] Rüdiger Hardeland. Curr Opin Investig Drugs. 2009. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. PubMed
235. [235] Michel Hoebert et al.. J Pineal Res. 2009. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. doi:10.1111/j.1600-079X.2009.00681.x PubMed
236. [236] Seithikurippu R Pandi-Perumal et al.. Nat Clin Pract Neurol. 2008. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. doi:10.1038/ncpneuro0847 PubMed
237. [237] Rüdiger Hardeland et al.. Arzneimittelforschung. 2008. Melatonergic drugs in clinical practice. doi:10.1055/s-0031-1296459 PubMed
238. [238] Venkataramanujan Srinivasan et al.. Travel Med Infect Dis. 2008. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. doi:10.1016/j.tmaid.2007.12.002 PubMed
239. [239] Syed H Tariq et al.. Clin Geriatr Med. 2008. Pharmacotherapy for insomnia. doi:10.1016/j.cger.2007.08.009 PubMed
240. [240] Michael J Sateia et al.. Sleep Med Rev. 2008. Efficacy and clinical safety of ramelteon: an evidence-based review. doi:10.1016/j.smrv.2007.12.005 PubMed
241. [241] W Braam et al.. J Intellect Disabil Res. 2008. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study. doi:10.1111/j.1365-2788.2007.01016.x PubMed
242. [242] Nalaka S Gooneratne. Clin Geriatr Med. 2008. Complementary and alternative medicine for sleep disturbances in older adults. doi:10.1016/j.cger.2007.08.002 PubMed
243. [243] Ana Barion et al.. Sleep Med. 2007. A clinical approach to circadian rhythm sleep disorders. doi:10.1016/j.sleep.2006.11.017 PubMed
244. [244] Anna K Morin et al.. Pharmacotherapy. 2007. Therapeutic options for sleep-maintenance and sleep-onset insomnia. doi:10.1592/phco.27.1.89 PubMed
245. [245] Donald L Bliwise et al.. Sleep. 2007. Insomnia associated with valerian and melatonin usage in the 2002 National Health Interview Survey. doi:10.1093/sleep/30.7.881 PubMed
246. [246] Louis J Mini et al.. Am J Geriatr Pharmacother. 2007. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. doi:10.1016/j.amjopharm.2007.09.004 PubMed
247. [247] Gary S Richardson et al.. Am J Manag Care. 2007. Circadian rhythmicity and the pharmacologic management of insomnia. PubMed
248. [248] Timothy I Morgenthaler et al.. Sleep. 2007. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. doi:10.1093/sleep/30.11.1445 PubMed
249. [249] Veronika Butterweck et al.. J Pharm Pharmacol. 2007. Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice. doi:10.1211/jpp.59.4.0009 PubMed
250. [250] Jonathan R L Schwartz et al.. Drugs. 2006. Shift work sleep disorder: burden of illness and approaches to management. doi:10.2165/00003495-200666180-00007 PubMed
251. [251] S R Pandi-Perumal et al.. FEBS J. 2006. Melatonin: Nature's most versatile biological signal? doi:10.1111/j.1742-4658.2006.05322.x PubMed
252. [252] Achille Norsa et al.. Cancer Biother Radiopharm. 2006. Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status. doi:10.1089/cbr.2006.21.68 PubMed
253. [253] Alfredo Bellon. J Psychiatr Pract. 2006. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial? doi:10.1097/00131746-200607000-00005 PubMed
254. [254] Kristiaan B Van der Heijden et al.. Chronobiol Int. 2005. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. doi:10.1081/CBI-200062410 PubMed
255. [255] Birgit M Dietz et al.. Brain Res Mol Brain Res. 2005. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. doi:10.1016/j.molbrainres.2005.04.009 PubMed
256. [256] Gary S Richardson. J Clin Psychiatry. 2005. The human circadian system in normal and disordered sleep. PubMed
257. [257] Fong-Fu Chou et al.. Surgery. 2005. Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism. doi:10.1016/j.surg.2004.12.010 PubMed
258. [258] Bihui Zhong et al.. J Cell Sci. 2004. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation. doi:10.1242/jcs.01016 PubMed
259. [259] Kathryn J Reid et al.. Semin Neurol. 2004. Circadian rhythm disorders. doi:10.1055/s-2004-835063 PubMed
260. [260] Fred W Turek et al.. Sleep Med. 2004. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. doi:10.1016/j.sleep.2004.07.009 PubMed
261. [261] C Cajochen et al.. J Neuroendocrinol. 2003. Role of melatonin in the regulation of human circadian rhythms and sleep. doi:10.1046/j.1365-2826.2003.00989.x PubMed
262. [262] Anna Ivanenko et al.. Clin Pediatr (Phila). 2003. Melatonin in children and adolescents with insomnia: a retrospective study. doi:10.1177/000992280304200108 PubMed
263. [263] H Niederhofer et al.. J Autism Dev Disord. 2003. Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia. doi:10.1023/a:1025027231938 PubMed
264. [264] Marcel G Smits et al.. J Am Acad Child Adolesc Psychiatry. 2003. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. doi:10.1097/01.chi.0000085756.71002.86 PubMed
265. [265] Uwe D Rohr et al.. Maturitas. 2002. Melatonin deficiencies in women. doi:10.1016/s0378-5122(02)00017-8 PubMed
266. [266] Michele M Larzelere et al.. Prim Care. 2002. Anxiety, depression, and insomnia. doi:10.1016/s0095-4543(01)00003-3 PubMed
267. [267] Ka Fai Chung et al.. Gen Hosp Psychiatry. 2002. Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents. doi:10.1016/s0163-8343(02)00210-4 PubMed
268. [268] M Rufo-Campos. Rev Neurol. 2002. [Melatonin and epilepsy]. PubMed
269. [269] J Durlach et al.. Magnes Res. 2002. Chronopathological forms of magnesium depletion with hypofunction or with hyperfunction of the biological clock. PubMed
270. [270] Daniel P Cardinali et al.. Neuro Endocrinol Lett. 2002. Melatonin in sleep disorders and jet-lag. PubMed
271. [271] Dieter Riemann et al.. Psychiatry Res. 2002. Nocturnal cortisol and melatonin secretion in primary insomnia. doi:10.1016/s0165-1781(02)00249-4 PubMed
272. [272] I V Zhdanova et al.. J Clin Endocrinol Metab. 2001. Melatonin treatment for age-related insomnia. doi:10.1210/jcem.86.10.7901 PubMed
273. [273] N Zisapel. CNS Drugs. 2001. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. doi:10.2165/00023210-200115040-00005 PubMed
274. [274] R P Brown et al.. J Psychiatr Pract. 2001. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. doi:10.1097/00131746-200103000-00002 PubMed
275. [275] A Balogh. Z Arztl Fortbild Qualitatssich. 2001. [Drug for the treatment of sleep disorders--review]. PubMed
276. [276] C J Klein. J Am Diet Assoc. 2000. Zinc supplementation. doi:10.1016/S0002-8223(00)00331-X PubMed
277. [277] S Carranza-Lira et al.. Med Sci Monit. 2000. Melatonin and climactery. PubMed
278. [278] L Wetterberg. Reprod Nutr Dev. 1999. Melatonin and clinical application. doi:10.1051/rnd:19990309 PubMed
279. [279] N Zisapel. Biol Signals Recept. 1999. The use of melatonin for the treatment of insomnia. doi:10.1159/000014574 PubMed
280. [280] C K Kirkwood. J Am Pharm Assoc (Wash). 1999. Management of insomnia. doi:10.1016/s1086-5802(15)30354-5 PubMed
281. [281] DR Wagner. Curr Treat Options Neurol. 1999. Circadian Rhythm Sleep Disorders. doi:10.1007/s11940-999-0020-x PubMed
282. [282] H J Bursztajn. Arch Intern Med. 1999. Melatonin therapy: from benzodiazepine-dependent insomnia to authenticity and autonomy. doi:10.1001/archinte.159.20.2393 PubMed
283. [283] A Ishizaki et al.. No To Hattatsu. 1999. [Usefulness of melatonin for developmental sleep and emotional/behavior disorders--studies of melatonin trial on 50 patients with developmental disorders]. PubMed
284. [284] A Samel. Eur J Med Res. 1999. Melatonin and jet-lag. PubMed
285. [285] J Wagner et al.. Ann Pharmacother. 1998. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. doi:10.1345/aph.17111 PubMed
286. [286] P M Sedgwick. Postgrad Med J. 1998. Disorders of the sleep-wake cycle in adults. doi:10.1136/pgmj.74.869.134 PubMed
287. [287] M Geoffriau et al.. Horm Res. 1998. The physiology and pharmacology of melatonin in humans. doi:10.1159/000023160 PubMed
288. [288] M J Cupp. Am Fam Physician. 1997. Melatonin. PubMed
289. [289] C M Ellis et al.. J Sleep Res. 1996. Melatonin and insomnia. doi:10.1046/j.1365-2869.1996.00003.x PubMed
290. [290] G Hajak et al.. Pharmacopsychiatry. 1996. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia. doi:10.1055/s-2007-979569 PubMed
291. [291] T Klein et al.. Sleep. 1993. Circadian sleep regulation in the absence of light perception: chronic non-24-hour circadian rhythm sleep disorder in a blind man with … doi:10.1093/sleep/16.4.333 PubMed
292. [292] J L Port et al.. Can J Microbiol. 1984. Sulphur acquisition by Neisseria meningitidis. doi:10.1139/m84-232 PubMed
293. [293] S Nakamura et al.. Microbiol Immunol. 1982. Carbohydrate fermentation by Clostridium difficile. doi:10.1111/j.1348-0421.1982.tb00159.x PubMed
294. [294] E Fuchs et al.. Cell. 1981. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. doi:10.1016/0092-8674(81)90169-0 PubMed